Selected published reports for 2007 and 2008

Ursula A. Matulonis, Neil S. Horowitz, Susana M. Campos, Hang Lee, Julie Lee, Carolyn N. Krasner, Suzanne Berlin, Maria Roche, Linda R. Duska, Lauren Pereira, Deborah Kendall. Richard T. Penson. Phase II of carboplatin and pemetrexed in patients with platinum sensitive recurrent ovarian cancer, accepted and in press. J Clin Oncol. 2008

U.A. Matulonis, A.B. Kornblith, H. Lee, J. Bryan, C. Gibson, C. Wells, J. Lee, L. Sullivan, R.T. Penson. Long-Term Adjustment of Early-Stage Ovarian Cancer Survivors.International Journal of Gynecologic Cancer 2008 Jan.

Stephen A. Cannistra, Ursula A. Matulonis, Richard T. Penson, Julie Hambleton, Jakob Dupont, Howard Mackey, Jeffrey Douglas, Robert A. Burger, Deborah Armstrong, Robert Wenham, William McGuire. Phase II Study of Bevacizumab in Patients with Platinum-Resistant Ovarian Cancer or Primary Peritoneal Serous Cancer. J Clin Oncol. 2007 Nov; 20;25(33):5180-6

Olawaiye A, Lee L, Krasner C, Horowitz N. Treatment of squamous cell vulvar cancer with anti-EGFR tyrosine kinase inhibitor Tarceva. Gyn Onc. 2007;106: 628-30

Abstracts for 2007 and 2008

W. P. McGuire, H. W. Hirte, U. A. Matulonis, R. T. Penson, A. Husain, P. J. Hoskins, J. Michels, G. Michelson, A. Chiang, C. A. Aghajanian. A phase II trial of SNS-595 in women with platinum resistant epithelial ovarian cancer.J Clin Oncol 26. 2008; May 20 suppl (abstr 5582).

M. C. Castells, N. M. Tennant, D. E. Sloane, F. I. Hsu, S. T. Berlin, S. M. Campos, U. A. Matulonis. Anaphylactic and anaphylactoid reactions to chemotherapy: outcomes and safety of rapid intravenous and intraperitoneal desensitizations in 413 cases.J Clin Oncol 26: 2008; May 20 suppl (abstr 5526).

U. A. Matulonis, S. T. Berlin, C. N. Krasner, K. Tyburski, J. Lee, M. Roche, S. P. Ivy, C. Lenahan, M. King, R. T. Penson. Cediranib (AZD2171) is an active agent in recurrent epithelial ovarian cancer.J Clin Oncol 26. 2008; May 20 suppl (abstr 5501).

N. S. Horowitz, R. T. Penson, S. M. Campos, J. Lee, D. L. Kendall, C. N. Krasner, S. T. Berlin, M. Roche, L. R. Duska, U. A. Matulonis. Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer.J Clin Oncol 26. 2008; May 20 suppl (abstr 5523).

K. Mirabeau-Beale, A. B. Kornblith, R. T. Penson, H. Lee, A. Goodman, S. M. Campos, L. R. Duska, L. Pereira, C. D. Gibson, U. A. Matulonis. Comparison of the quality of life of early and advanced stage ovarian cancer survivors.J Clin Oncol 26. 2008; May 20 suppl (abstr 5528).

A. H. Gross, J. Cromwell, A. B. Kornblith, H. Lee, H. Li, L. Pereira, R. T. Penson, U. A. Matulonis. Effects of complementary and alternative medicine use on hopelessness in ovarian cancer patients.J Clin Oncol 26. 2008; May 20 suppl (abstr 9598).

L. Amler, S. Makhija, T. Januario, U. A. Matulonis, A. Strauss, D. S. Dizon, M. X. Sliwkowski, M. Dolezal, B. Tong, V. Paton. HER pathway gene expression analysis in a phase II study of pertuzumab + gemcitabine vs. gemcitabine + placebo in patients with platinum-resistant epithelial ovarian cancer.J Clin Oncol 26. 2008; May 20 suppl (abstr 5552).

C. N. Krasner, M. V. Seiden, R. T. Penson, M. Roche, D. L. Kendall, J. Young, U. A. Matulonis, L. Pereira, S. T. Berlin. NOV-002 plus carboplatin in platinum-resistant ovarian cancer.J Clin Oncol 26. 2008; May 20 suppl (abstr 5593).

R. T. Penson, A. B. Kornblith, J. Lee, M. Roche, T. Atkinson, C. D. Gibson, N. S. Horowitz, K. J. Krag, C. N. Krasner, U. A. Matulonis. Phase II study of carboplatin and paclitaxel in elderly women with newly diagnosed ovarian, peritoneal, or fallopian tube cancer.J Clin Oncol 26. 2008; May 20 suppl (abstr 5590).

AACR/NCI/ EORTC Molecular Therapeutics Meeting, 10/07

• Phase II study of Cediranib (RECENTIN, AZD2171) in recurrent epithelial ovarian cancer: Ursula Matulonis, Suzanne Berlin

European Society of Gynaecological Oncology, 10/07

• Phase II of carbo/alimta in platinum-resistant recurrent ovarian cancer: Ursula Matulonis
• Phase I of Doxil+ iressa for recurrent ovarian cancer: Susana Campos